2018

In early February 2018, Express Scripts Institute (ESI) released the 2017 Drug Report, which included new data that showed…

A new draft guidance from FDA explains how sponsors can submit a formal request for a meeting, which can be face-to-face,…

Senator Claire McCaskill recently introduced legislation that would eliminate the ability of drug manufacturers to deduct the cost…

According to data from CMS, the percentage of long-term nursing home residents being given antipsychotic drugs dropped from about…

Pharmaceutical and Device Payment Transparency is making its way to our Northern neighbor, Canada. On December 12, 2017, the…

Price transparency is such a hot topic today that it is oftentimes hard to keep up with the different state legislatures that are…

On January 29, 2018, Mississippi Attorney General Jim Hood announced a $33 million settlement with pharmaceutical manufacturer,…

Recently, the House Energy & Commerce Health Subcommittee announced that it will hold a hearing on Wednesday, February 28,…

The Trump Administration recently adopted new limits on the use of “guidance documents” issued by federal agencies. Various…

On February 8, 2018, the Senate Health, Education, Labor, and Pensions (HELP) committee held a hearing entitled “Impact of the…